FDA Approves PET Imaging Compound to Aid Early Diagnosis and Disease Monitoring

The Feinstein Institutes for Medical Research announced that the U.S. Food and Drug Administration (FDA) has approved an imaging compound its researchers developed as a diagnostic tool for people with suspected parkinsonian syndromes, including Parkinson’s disease. Fluorodopa F18 (FDOPA) is an injectable compound used during a PET scan to mark the dopaminergic nerve terminals that…

New medical imaging allows better treatment and diagnoses of prostate cancer

The interview with Dr. Aoun originally appeared on OncLive, the official site of the Oncology Specialty Group, which publishes OncologyLive, Urologists in Cancer Care, and Oncology Nursing News. Novel next-generation imaging modalities have greater visibility than conventional imaging tools, leading to higher detection rates and earlier treatment of early recurrences and metastatic disease among men…

Kentucky sees increasse in lung cancer cases

According to the CDC, Kentucky ranks first in the nation for lung cancer deaths. Border states Ohio and Indiana are ranked at numbers 11 and five. Kentucky’s lung cancer incidence rate was 92.6 out of 100,000 people. The national rate is 59.6 In November 2019, the American Lung Association reported Kentucky has the highest rates…

© 2017 Designed and Hosted by McNee Solutions